In the first half of 2013 DYCONEX AG invested into several pieces of equipment that will further enhance production technology providing optimized PCB solutions for customers.
The purchase of the field-proven Orbotech ParagonTM-9800 Laser Direct Imaging (LDI) system - as the third LDI system in production - is another step in pursuing our strategy to convert all exposure jobs to direct imaging.
The Sorin Group Cardiac Rhythm Management Business Unit (Sorin CRM) has honored DYCONEX as the best supplier for printed circuit boards in 2012. The prize was handed over in mid June 2013 as part of the annual supplier event in Clamart, France.
Medical Design & Manufacturing
February 11 - 13, 2014
Convention Center Anaheim, CA, USA
Hall E, Booth# 618
Cytotoxicity, a standardized test for materials used in medical devices, is used to determine if significant quantities of harmful extractable substances are present and how these may negatively affect cellular components. Harlan Cytotest Cell Research GmbH recently performed a cytotoxicity test on an LCP product manufactured by DYCONEX and certified in an official declaration the non-cytotoxicity of the product and it's suitability for in-vitro application.
Due to its biocompatibility, hermeticity properties, chemical inertness and advantageous electromechanical properties, LCP circuit boards are especially well-suited for biomedical and temporary implantable applications.
© 2013 Micro Systems Technologies, CH-6341 Baar, Switzerland
DYCONEX AG, CH-8303 Bassersdorf, Switzerland